Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
GS 9450 (formerly LB84451)
print preview
bookmark
share with colleague
General Information
Company
LG Life Sciences Ltd.
Description
Oral, once-daily pan-caspase inhibitor
Molecular Target
Caspases
Mechanism of Action
Caspase inhibitor
Latest Stage of Development
Phase II
Indication
Hepatitis
Partner
Gilead Sciences Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy